Bhavesh D Kevadiya
Overview
Explore the profile of Bhavesh D Kevadiya including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
1401
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Razavi M, Primavera R, Kevadiya B, Wang J, Ullah M, Buchwald P, et al.
Nano Lett
. 2022 Mar;
22(7):3174.
PMID: 35289180
No abstract available.
12.
Herskovitz J, Hasan M, Patel M, Kevadiya B, Gendelman H
Methods Mol Biol
. 2022 Jan;
2407:429-445.
PMID: 34985679
First identified as a viral defense mechanism, clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated proteins (Cas) has been transformed into a gene-editing tool. It now affords promise in...
13.
Machhi J, Yeapuri P, Lu Y, Foster E, Chikhale R, Herskovitz J, et al.
J Neuroinflammation
. 2021 Nov;
18(1):272.
PMID: 34798897
Background: Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by pathological deposition of misfolded self-protein amyloid beta (Aβ) which in kind facilitates tau aggregation and neurodegeneration. Neuroinflammation is accepted...
14.
Herskovitz J, Hasan M, Patel M, Blomberg W, Cohen J, Machhi J, et al.
EBioMedicine
. 2021 Nov;
73:103678.
PMID: 34774454
Background: A barrier to HIV-1 cure rests in the persistence of proviral DNA in infected CD4+ leukocytes. The high HIV-1 mutation rate leads to viral diversity, immune evasion, and consequent...
15.
Primavera R, Bellotti E, Di Mascolo D, di Francesco M, Wang J, Kevadiya B, et al.
ACS Appl Mater Interfaces
. 2021 Nov;
13(45):53618-53629.
PMID: 34751556
Type-1 diabetes (T1DM) is a chronic metabolic disorder resulting from the autoimmune destruction of β cells. The current standard of care requires multiple, daily injections of insulin and accurate monitoring...
16.
Liu X, Liu Y, Thakor A, Kevadiya B, Cheng J, Chen M, et al.
Acta Biomater
. 2021 Oct;
136:485-494.
PMID: 34601108
Carbon nanodots based on L-arginine (L-Arg) were developed for enhanced nitric oxide (NO) gas therapy for cancer. The L-Arg-based carbon nanodots (Arg-dots) produced high levels of NO in the tumor...
17.
Patel M, Shahjin F, Cohen J, Hasan M, Machhi J, Chugh H, et al.
FEMS Microbiol Rev
. 2021 Jun;
45(6).
PMID: 34160586
Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can lead to coronavirus disease 2019 (COVID-19). Virus-specific immunity controls infection, transmission and disease severity. With respect to disease severity, a...
18.
Herskovitz J, Hasan M, Machhi J, Mukadam I, Ottemann B, Hilaire J, et al.
Nanotheranostics
. 2021 May;
5(4):417-430.
PMID: 33972918
Delivery of long-acting nanoformulated antiretroviral drugs (ARVs) to human immunodeficiency virus type one cell and tissue reservoirs underlies next generation antiretroviral therapeutics. Nanotheranostics, comprised of trackable nanoparticle adjuncts, can facilitate...
19.
Kevadiya B, Machhi J, Herskovitz J, Oleynikov M, Blomberg W, Bajwa N, et al.
Nat Mater
. 2021 Feb;
20(5):593-605.
PMID: 33589798
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread to nearly every corner of the globe, causing societal instability. The resultant coronavirus disease 2019 (COVID-19) leads to fever, sore throat,...
20.
Machhi J, Shahjin F, Das S, Patel M, Abdelmoaty M, Cohen J, et al.
J Neuroimmune Pharmacol
. 2021 Feb;
16(2):270-288.
PMID: 33544324
Extracellular vesicles (EVs) are the common designation for ectosomes, microparticles and microvesicles serving dominant roles in intercellular communication. Both viable and dying cells release EVs to the extracellular environment for...